1. Feasibility study of the safety and activity of autologous bone marrow aspirate concentrate (bmac) for the treatment of non reconstructable critical limb ischemia due to peripheral arterial occlusive disease.
2. A Non-Randomized Open Label, Multicentric, Dose Ranging Phase II Study Assessing the Efficacy and Safety of Intramuscular Administration of Stempeucel - CLITM (Ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells) in Patients with Critical Limb Ischemia due to Buerger's Disease.
3. "A Phase II, Randomized Prospective, Double blind, Parallel group, Multi-Centre Study to determine the safety and efficacy of GRANEXIN GEL in the Treatment of Venous by Ulcer.
Feb14From 14th to 21st February 2021
3:00 PM - 9:00 PM